The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Estimating the financial cost of chronic kidney disease to the NHS in England
Open accessAbstract
BACKGROUND: Chronic kidney disease (CKD) is a major challenge for health care systems around the world, and the prevalence rates appear to be increasing. We estimate the costs of CKD in a universal health care system. METHODS: Economic modelling was used to estimate the annual cost of Stages 3-5 CKD to the National Health Service (NHS) in England, including CKD-related prescribing and care, renal replacement therapy (RRT), and excess strokes, myocardial infarctions (MIs) and Methicillin-Resistant Staphylococcus Aureus (MRSA) infections in people with CKD. RESULTS: The cost of CKD to the English NHS in 2009-10 is estimated at £ 1.44 to £ 1.45 billion, which is ≈ 1.3% of all NHS spending in that year. More than half this sum was spent on RRT, which was provided for 2% of the CKD population. The economic model estimates that ≈ 7000 excess strokes and 12 000 excess MIs occurred in the CKD population in 2009-10, relative to an age- and gender-matched population without CKD. The cost of excess strokes and MIs is estimated at £ 174-£ 178 million. CONCLUSIONS: The financial impact of CKD is large, with particularly high costs relating to RRT and cardiovascular complications. It is hoped that these detailed cost estimates will be useful in analysing the cost-effectiveness of treatments for CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
MacLeod, A. M. (2009) · Kidney International · Cited by 2,218
Weiner, D. E., Tighiouart, H., Amin, M. G., Stark, P. C., MacLeod, B., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000123691.46138.e2 · Cited by 1,176
Jafar, T. H., Schmid, C. H., Landa, M., Giatras, I., Toto, R., Remuzzi, G., Maschio, G., Brenner, B. M., Kamper, A., Zucchelli, P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-2-200107170-00007 · Cited by 1,092
Stroke incidence and prevalence in Europe: a review of available data
Truelsen, T., Piechowski‐Jóźwiak, B., Bonita, R., Mathers, C., Bogousslavsky, J., & Boysen, G. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01138.x · Cited by 665
Chronic kidney disease management in the United Kingdom: NEOERICA project results
Stevens, P. E., O'Donoghue, D. J., de Lusignan, S., Van Vlymen, J., Klebe, B., Middleton, R., Hague, N., New, J., & Farmer, C. K. T. (2007) · Kidney International · doi:10.1038/sj.ki.5002273 · Cited by 434
Self-citationThe socioeconomic burden of hospital acquired infection
Plowman, R. (2000) · Eurosurveillance · doi:10.2807/esm.05.04.00004-en · Cited by 397
Evidence for high risk of cerebral hemorrhage in chronic dialysis patients
Iseki, K., Kinjo, K., Kimura, Y., Osawa, A., & Fukiyama, K. (1993) · Kidney International · doi:10.1038/ki.1993.352 · Cited by 222
The burden of chronic kidney disease
Hamer, R. A., & Nahas, A. M. E. (2006) · BMJ · doi:10.1136/bmj.332.7541.563 · Cited by 218
Cited by
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Chronic kidney disease and the global public health agenda: an international consensus
Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00820-6 · Cited by 1,374
Evolving importance of kidney disease: from subspecialty to global health burden
Eckardt, K.-U., Coresh, J., Devuyst, O., Johnson, R. J., Köttgen, A., Levey, A. S., & Levin, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60439-0 · Cited by 1,159
Lapi, F., Azoulay, L., Yin, H., Nessim, S. J., & Suissa, S. (2013) · BMJ · doi:10.1136/bmj.e8525 · Cited by 393
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action
on behalf of the European Kidney Health Alliance, Vanholder, R., Annemans, L., Brown, E., Gansevoort, R., Gout-Zwart, J. J., Lameire, N., Morton, R. L., Oberbauer, R., Postma, M. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.63 · Cited by 368
Metadata
- Authors
- Kerr, M., Bray, B., Medcalf, J., O'Donoghue, D. J., & Matthews, B.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-05
- Volume
- 27
- Issue
- suppl_3
- Pages
- iii73-iii80
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2106610064
- Cited by
- 362
- References
- 16
- FWCI
- 53.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimating the financial cost of chronic kidney disease to the NHS in England. https://app.cochat.ai/papers/10.1093/ndt/gfs269
- The paper
- Kerr, M., Bray, B., Medcalf, J., O'Donoghue, D. J., & Matthews, B. (2012). Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfs269
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.